Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Slow Capital Inc.

Slow Capital Inc. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,660 shares of the medical equipment provider’s stock after buying an additional 28 shares during the quarter. Intuitive Surgical makes up 3.0% of Slow Capital Inc.’s holdings, making the stock its 8th biggest holding. Slow Capital Inc.’s holdings in Intuitive Surgical were worth $21,223,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Mirador Capital Partners LP grew its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $82,517,000. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp lifted its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.8 %

Shares of NASDAQ ISRG opened at $573.48 on Tuesday. The firm’s 50-day moving average price is $547.16 and its 200-day moving average price is $505.21. The firm has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. CICC Research initiated coverage on Intuitive Surgical in a report on Monday. They issued a “neutral” rating and a $550.00 target price for the company. UBS Group upped their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday. Truist Financial boosted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday. Finally, Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,265 shares of company stock valued at $21,964,281. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.